We are seeing a massive paradigm shift in the world of therapeutics. The market for biopharmaceuticals where the drug itself is made of biological substances like antibodies is rapidly expanding. And now, we are entering into a new era of regenerative medicine, where cells, tissues, and organ systems created in the lab will become the next generation of therapeutics – the next frontier in medicine. In this presentation, we will talk about how 3D printing, material science, and biology are being combined to create implantable, living tissue therapeutics that could replace or repair damaged organ and biological functions inside of the human body
Access to the requested content is limited to institutions that have purchased or subscribe to SPIE eBooks.
You are receiving this notice because your organization may not have SPIE eBooks access.*
*Shibboleth/Open Athens users─please
sign in
to access your institution's subscriptions.
To obtain this item, you may purchase the complete book in print or electronic format on
SPIE.org.
INSTITUTIONAL Select your institution to access the SPIE Digital Library.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.